133 related articles for article (PubMed ID: 1840290)
21. [Antitumor photochemotherapy: biochemical bases, therapeutic uses and perspectives].
Mazière JC; Morlière P; Biade S; Santus R
C R Seances Soc Biol Fil; 1992; 186(1-2):88-106. PubMed ID: 1450993
[TBL] [Abstract][Full Text] [Related]
22. Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins.
Hamblin MR; Newman EL
J Photochem Photobiol B; 1994 Nov; 26(2):147-57. PubMed ID: 7815189
[TBL] [Abstract][Full Text] [Related]
23. [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells].
Li W; Xi S; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):636-8. PubMed ID: 16200711
[TBL] [Abstract][Full Text] [Related]
24. Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors?
Korbelik M
J Photochem Photobiol B; 1992 Jan; 12(1):107-9. PubMed ID: 1531856
[No Abstract] [Full Text] [Related]
25. VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body.
Yamamoto H; Takada T; Yamanashi Y; Ogura M; Masuo Y; Harada-Shiba M; Suzuki H
Sci Rep; 2017 Apr; 7(1):633. PubMed ID: 28377633
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol uptake by human glioma cells via receptor-mediated endocytosis of low-density lipoprotein.
Murakami M; Ushio Y; Mihara Y; Kuratsu J; Horiuchi S; Morino Y
J Neurosurg; 1990 Nov; 73(5):760-7. PubMed ID: 2120396
[TBL] [Abstract][Full Text] [Related]
27. Assimilation of LDL by experimental tumours in mice.
Lombardi P; Norata G; Maggi FM; Canti G; Franco P; Nicolin A; Catapano AL
Biochim Biophys Acta; 1989 Jun; 1003(3):301-6. PubMed ID: 2500972
[TBL] [Abstract][Full Text] [Related]
28. Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster.
Spady DK; Meddings JB; Dietschy JM
J Clin Invest; 1986 May; 77(5):1474-81. PubMed ID: 3700649
[TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts.
Polo L; Valduga G; Jori G; Reddi E
Int J Biochem Cell Biol; 2002 Jan; 34(1):10-23. PubMed ID: 11733181
[TBL] [Abstract][Full Text] [Related]
30. Low density lipoprotein as a targeted carrier for doxorubicin in nude mice bearing human hepatoma HepG2 cells.
Chu AC; Tsang SY; Lo EH; Fung KP
Life Sci; 2001 Dec; 70(5):591-601. PubMed ID: 11811903
[TBL] [Abstract][Full Text] [Related]
31. Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo.
Barel A; Jori G; Perin A; Romandini P; Pagnan A; Biffanti S
Cancer Lett; 1986 Aug; 32(2):145-50. PubMed ID: 3756840
[TBL] [Abstract][Full Text] [Related]
32. Low density lipoprotein-receptor activity is lost in vivo in malignantly transformed renal tissue.
Clayman RV; Bilhartz LE; Spady DK; Buja LM; Dietschy JM
FEBS Lett; 1986 Feb; 196(1):87-90. PubMed ID: 3484708
[TBL] [Abstract][Full Text] [Related]
33. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.
Rensen PC; Schiffelers RM; Versluis AJ; Bijsterbosch MK; Van Kuijk-Meuwissen ME; Van Berkel TJ
Mol Pharmacol; 1997 Sep; 52(3):445-55. PubMed ID: 9281607
[TBL] [Abstract][Full Text] [Related]
34. Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro.
Samadi-Baboli M; Favre G; Blancy E; Soula G
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):233-41. PubMed ID: 2702978
[TBL] [Abstract][Full Text] [Related]
35. Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.
Vitols S; Söderberg-Reid K; Masquelier M; Sjöström B; Peterson C
Br J Cancer; 1990 Nov; 62(5):724-9. PubMed ID: 2245164
[TBL] [Abstract][Full Text] [Related]
36. Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms.
Gal D; Ohashi M; MacDonald PC; Buchsbaum HJ; Simpson ER
Am J Obstet Gynecol; 1981 Apr; 139(8):877-85. PubMed ID: 7223790
[TBL] [Abstract][Full Text] [Related]
37. Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms.
Bhuiyan H; Masquelier M; Tatidis L; Gruber A; Paul C; Vitols S
Lipids; 2017 Jun; 52(6):523-534. PubMed ID: 28488049
[TBL] [Abstract][Full Text] [Related]
38. Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells.
Peterson C; Vitols S; Rudling M; Blomgren H; Edsmyr F; Skoog L
Med Oncol Tumor Pharmacother; 1985; 2(3):143-7. PubMed ID: 4068801
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles with High-Surface Negative-Charge Density Disturb the Metabolism of Low-Density Lipoprotein in Cells.
Bai X; Zhang J; Chang YN; Gu W; Lei R; Qin Y; Xia S; Ma S; Liang Y; Chen K; Li J; Sun B; Xing G
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227604
[TBL] [Abstract][Full Text] [Related]
40. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.
Allison BA; Pritchard PH; Levy JG
Br J Cancer; 1994 May; 69(5):833-9. PubMed ID: 8180011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
